Form 8-K - Current report:
SEC Accession No. 0001144204-16-111871
Filing Date
2016-07-07
Accepted
2016-07-07 07:36:38
Documents
2
Period of Report
2016-07-07
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K v443762_8k.htm 8-K 18205
2 EXHIBIT 99.1 v443762_ex99-1.htm EX-99.1 10444
  Complete submission text file 0001144204-16-111871.txt   29978
Mailing Address 2 SNUNIT ST SCIENCE PARK, POB 455 CARMIEL L3 20100
Business Address 2 SNUNIT ST SCIENCE PARK, POB 455 CARMIEL L3 20100 972-4-988-9488
Protalix BioTherapeutics, Inc. (Filer) CIK: 0001006281 (see all company filings)

EIN.: 650643773 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-33357 | Film No.: 161755519
SIC: 2836 Biological Products, (No Diagnostic Substances)